Acasti Pharma | ACST - Operating Expenses

Stock Price
2.30
Daily Change
-0.05 -2.13%
Monthly
-50.96%
Yearly
-7.63%
Q2 Forecast
2.25

Acasti Pharma reported $62.82M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Acasti Pharma USD 62.82M 59.73M Sep/2025
Addus HomeCare USD 330.8M 1.44M Dec/2025
Amarin USD 51.48M 113K Dec/2025
Cassava Sciences USD 13.55M 1.69M Dec/2025
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Option Care Health USD 1.37B 23.44M Dec/2025
Organigram Holdings CAD 83.66M 24.44M Dec/2025
Tilray USD 237.52M 17.34M Sep/2025